Regadenoson recalls
The FDA has published 1 recall involving Regadenoson since 2024. The latest was reported on 13 Nov 2024. Most were for labeling errors. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2024
Last 12 months0reported
Class I00% of total
Ongoing1latest 13 Nov 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why regadenoson is recalled
Companies
By year
Ongoing regadenoson recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Regadenoson Injection, 0.4 mg recalled by Baxter HealthcareRegadenoson | Baxter Healthcare | Labeling Errors | Nationwide |
All regadenoson recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Regadenoson Injection, 0.4 mg recalled by Baxter HealthcareRegadenoson | Baxter Healthcare | Labeling Errors | Nationwide |
Should you stop taking Regadenoson?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.